Der p 38

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Inflammation (Inflammations) 10/01/2021 - "Persistent Der p 38 administration induced severe neutrophil inflammation. " 10/01/2021 - "These findings may contribute to a deep understanding of Der p 38 as a bridge allergen between eosinophilic and neutrophilic inflammation in the pathogenic mechanisms of allergy."
2.	Hypersensitivity (Allergy) 10/01/2021 - "Der p 38 Is a Bidirectional Regulator of Eosinophils and Neutrophils in Allergy." 10/01/2021 - "These findings may contribute to a deep understanding of Der p 38 as a bridge allergen between eosinophilic and neutrophilic inflammation in the pathogenic mechanisms of allergy."
3.	Atopic Dermatitis (Atopic Eczema) 01/01/2021 - "Pathogenic Mechanism of Der p 38 as a Novel Allergen Homologous to RipA and RipB Proteins in Atopic Dermatitis."
4.	Asthma (Bronchial Asthma) 10/01/2021 - "In animal experiments with wild-type and TLR4 knockout BALB/c mice, Der p 38 administration induced the infiltration of neutrophils as well as eosinophils and exhibited clinical features similar to asthma via TLR4 activation. "